Bulk Manufacturer of Controlled Substances Application: Ampac Fine Chemicals LLC, 44924 [2020-16104]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
44924
Federal Register / Vol. 85, No. 143 / Friday, July 24, 2020 / Notices
contacting the Commission’s TDD
terminal on (202) 205–1810.
SUPPLEMENTARY INFORMATION: The
Commission instituted this investigation
on September 13, 2018, based on a
complaint, as amended, filed by FCA
US LLC of Auburn Hills, Michigan
(‘‘Complainant’’). See 83 FR 46517
(Sept. 13, 2018). The complaint alleges
violations of section 337 based upon the
importation into the United States, the
sale for importation, and the sale within
the United States after importation of
certain motorized vehicles and
components thereof by reason of: (1)
Infringement of U.S. Trademark
Registration Nos. 4,272,873; 2,862,487;
2,161,779; 2,794,553; and 4,043,984
(collectively, ‘‘the Asserted
Trademarks’’); (2) trademark dilution
and unfair competition in violating the
complainant’s common law trademark
rights; and (3) trade dress infringement.
See id. The notice of investigation
names Mahindra & Mahindra Ltd. of
Mumbai, India and Mahindra
Automotive North America, Inc. of
Auburn Hills, Michigan (collectively,
‘‘Respondents’’) as respondents in this
investigation. See id. The Office of
Unfair Import Investigations is also a
party to this investigation. See id.
The ALJ conducted an evidentiary
hearing on August 19–23, 2019. On
November 8, 2019, the ALJ issued a
final initial determination (‘‘FID’’)
finding a violation of section 337.
Specifically, the FID determined that
Respondents’ Roxor vehicle (2018–2019
model) infringes FCA’s asserted trade
dress but not its Asserted Trademarks.
The FID also determined that
Complainant did not establish
trademark dilution.
On June 11, 2020, the Commission
determined to affirm the FID’s
determination of a violation of section
337. The Commission issued an LEO
barring entry of articles that infringe the
asserted trade dress and a CDO against
both Respondents. The Commission
declined to adjudicate Respondents’
proposed redesigned vehicles and
required Respondents to obtain a ruling
(via an advisory opinion or a
modification proceeding) from the
Commission prior to any importation of
redesigned vehicles or components
thereof.
On June 18, 2020, Respondents filed
a petition for an expedited modification
proceeding as to two redesigned
vehicles, namely the 2020 Roxor vehicle
and the Post-2020 Roxor vehicle.
Respondents further request, should the
Commission determine that the 2020
Roxor vehicle requires more time, that
the Commission institute a modification
VerDate Sep<11>2014
20:45 Jul 23, 2020
Jkt 250001
proceeding only as to the Post-2020
ROXOR vehicle. On June 29, 2020,
Complainant filed a response in
opposition to Respondents’ petition.
OUII did not file a response to the
petition. On July 7, 2020, Respondents
filed a motion for leave to file a reply
in support of their petition for an
expedited modification proceeding,
which is hereby GRANTED.
The Commission has determined to
institute a modification proceeding
under 19 U.S.C. 1337(k) and 19 CFR
210.76 to adjudicate infringement with
respect to Respondents’ Post-2020
ROXOR vehicle. The Commission has
also determined to delegate the
modification proceeding to the Chief
ALJ to designate a presiding ALJ to
make all necessary factual and legal
findings and to issue a recommended
determination as to whether the
Commission shall modify the remedial
orders to explicitly exempt
Respondents’ Post-2020 ROXOR
vehicle. The Commission has further
determined to set the deadline for the
ALJ to issue a recommended
determination to three months from
issuance of this notice. Should the ALJ
determine that more time is necessary,
the deadline may be extended for good
cause shown.
The Commission’s vote on this
determination took place on July 20,
2020.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: July 20, 2020.
Lisa Barton,
Secretary to the Commission.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–686]
Bulk Manufacturer of Controlled
Substances Application: Ampac Fine
Chemicals LLC
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 22, 2020.
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Controlled substance
Methylphenidate ............
Levomethorphan ............
Levorphanol ...................
Thebaine ........................
Remifentanil ...................
Tapentadol .....................
Drug
code
1724
9210
9220
9333
9739
9780
Schedule
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances for
distribution to its customers.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–16104 Filed 7–23–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–686]
Bulk Manufacturer of Controlled
Substances Application: Ampac Fine
Chemicals LLC
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 22, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
BILLING CODE 7020–02–P
DATES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 12, 2020, Ampac
Fine Chemicals LLC, Highway 50 and
Hazel Avenue, Rancho Cordova,
California 95670, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
SUPPLEMENTARY INFORMATION:
ACTION:
[FR Doc. 2020–16028 Filed 7–23–20; 8:45 am]
ACTION:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 12, 2020, Ampac
Fine Chemicals LLC, Highway 50 and
Hazel Avenue, Rancho Cordova,
California 95670, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\24JYN1.SGM
24JYN1
]]>Agencies
[Federal Register Volume 85, Number 143 (Friday, July 24, 2020)]
[Notices]
[Page 44924]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16104]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-686]
Bulk Manufacturer of Controlled Substances Application: Ampac
Fine Chemicals LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before September 22,
2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on March 12, 2020, Ampac Fine Chemicals LLC, Highway 50
and Hazel Avenue, Rancho Cordova, California 95670, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Methylphenidate........................ 1724 II
Levomethorphan......................... 9210 II
Levorphanol............................ 9220 II
Thebaine............................... 9333 II
Remifentanil........................... 9739 II
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
for distribution to its customers.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-16104 Filed 7-23-20; 8:45 am]
BILLING CODE 4410-09-P
